Ramucirumab, Atezolizumab and N-803 After Progression on Any Immune Checkpoint Blocker in NSCLC

Clinical trial NCT05007769 · WITHDRAWN

Trial details

NCT number: NCT05007769
Sponsor: Washington University School of Medicine
Status: WITHDRAWN
Phase: Phase 2
Study type: INTERVENTIONAL

Non-small Cell Lung Cancer Non-small Cell Carcinoma NSCLC Non Small Cell Lung Cancer

Start date: 2021-10-31
Primary completion: 2024-04-30
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.